Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Eder

Showing results (211-220 of 283) with videos related to

Pageof 29
Sort By:
Cancer Research|January 5, 2019
Bicyclic Peptides as a New Modality for Imaging and Targeting of Proteins Overexpressed by TumorsMatthias Eder, Silvia Pavan, Ulrike Bauder-Wüst, et al.
Haematologica|February 4, 2017
Suppression of RUNX1/ETO oncogenic activity by a small molecule inhibitor of tetramerizationJulia Schanda, Chun-Wei Lee, Katharina Wohlan, et al.
Biological Psychiatry Global Open Science|January 19, 2026
Mineralocorticoid Receptor in Glutamatergic Neurons Modulates Anxiety Exclusively in Male Mice Via Regulation of the Actin-Bundling Factor Fam107aHuanqing Yang, Sowmya Narayan, Joeri Bordes, et al.
Leukemia|November 4, 2021
A unique role of p53 haploinsufficiency or loss in the development of acute myeloid leukemia with FLT3-ITD mutationMin Yang, Zengkai Pan, Kezhi Huang, et al.
Bone Marrow Transplantation|May 29, 2025
Prognostic significance of cytogenetic risk score in patients with secondary acute myeloid leukemia undergoing allogeneic stem cell transplantation from HLA-matched unrelated donors: a study from the ALWP /EBMTArnon Nagler, Allain-Thibeault Ferhat, Sarah Kayser, et al.
British Journal of Haematology|November 5, 2019
FLA-IDA salvage chemotherapy combined with a seven-day course of venetoclax (FLAVIDA) in patients with relapsed/refractory acute leukaemiaRabia Shahswar, Gernot Beutel, Piroska Klement, et al.
Leukemia|April 17, 2025
GVHD prophylaxis in matched related stem cell transplantation: Why post-transplant cyclophosphamide can be recommended a study by the EBMT transplant complications working partyOlaf Penack, Mouad Abouqateb, Christophe Peczynski, et al.
Bone Marrow Transplantation|February 12, 2025
Cytogenetic and molecular risk-driven conditioning intensity in acute myeloid leukemia patients undergoing stem cell transplantation with post-transplant cyclophosphamide: a study from the acute leukemia working party of the EBMTJaime Sanz, Myriam Labopin, Jurjen Versluis, et al.
Transplantation and Cellular Therapy|April 13, 2026
Survival trends in young adults with acute leukaemia after AHSCT in Germany: comparisons with younger and older patientsJochen J Frietsch, Sarah Flossdorf, Ashrafossadat Ahmadian, et al.
Science (New York, N.Y.)|October 4, 2003
CB1 cannabinoid receptors and on-demand defense against excitotoxicityGiovanni Marsicano, Sharon Goodenough, Krisztina Monory, et al.
Pageof 29

Showing results (211-220 of 283) with videos related to

Sort By:
Pageof 29
Cancer Research|January 5, 2019
Bicyclic Peptides as a New Modality for Imaging and Targeting of Proteins Overexpressed by TumorsMatthias Eder, Silvia Pavan, Ulrike Bauder-Wüst, et al.
Haematologica|February 4, 2017
Suppression of RUNX1/ETO oncogenic activity by a small molecule inhibitor of tetramerizationJulia Schanda, Chun-Wei Lee, Katharina Wohlan, et al.
Biological Psychiatry Global Open Science|January 19, 2026
Mineralocorticoid Receptor in Glutamatergic Neurons Modulates Anxiety Exclusively in Male Mice Via Regulation of the Actin-Bundling Factor Fam107aHuanqing Yang, Sowmya Narayan, Joeri Bordes, et al.
Leukemia|November 4, 2021
A unique role of p53 haploinsufficiency or loss in the development of acute myeloid leukemia with FLT3-ITD mutationMin Yang, Zengkai Pan, Kezhi Huang, et al.
Bone Marrow Transplantation|May 29, 2025
Prognostic significance of cytogenetic risk score in patients with secondary acute myeloid leukemia undergoing allogeneic stem cell transplantation from HLA-matched unrelated donors: a study from the ALWP /EBMTArnon Nagler, Allain-Thibeault Ferhat, Sarah Kayser, et al.
British Journal of Haematology|November 5, 2019
FLA-IDA salvage chemotherapy combined with a seven-day course of venetoclax (FLAVIDA) in patients with relapsed/refractory acute leukaemiaRabia Shahswar, Gernot Beutel, Piroska Klement, et al.
Leukemia|April 17, 2025
GVHD prophylaxis in matched related stem cell transplantation: Why post-transplant cyclophosphamide can be recommended a study by the EBMT transplant complications working partyOlaf Penack, Mouad Abouqateb, Christophe Peczynski, et al.
Bone Marrow Transplantation|February 12, 2025
Cytogenetic and molecular risk-driven conditioning intensity in acute myeloid leukemia patients undergoing stem cell transplantation with post-transplant cyclophosphamide: a study from the acute leukemia working party of the EBMTJaime Sanz, Myriam Labopin, Jurjen Versluis, et al.
Transplantation and Cellular Therapy|April 13, 2026
Survival trends in young adults with acute leukaemia after AHSCT in Germany: comparisons with younger and older patientsJochen J Frietsch, Sarah Flossdorf, Ashrafossadat Ahmadian, et al.
Science (New York, N.Y.)|October 4, 2003
CB1 cannabinoid receptors and on-demand defense against excitotoxicityGiovanni Marsicano, Sharon Goodenough, Krisztina Monory, et al.
Pageof 29